Expert consensus on the diagnosis and treatment of heat stroke in China

Abstract

Heat stroke (HS) is a fatal disease caused by thermal damage in the body, and it has a very high mortality rate. In 2015, the People's Liberation Army Professional Committee of Critical Care Medicine published the first expert consensus on HS in China, Expert consensus on standardized diagnosis and treatment for heat stroke. With an increased understanding of HS and new issues that emerged during the HS treatment in China in recent years, the 2015 consensus no longer meet the requirements for HS prevention and treatment. It is necessary to update the consensus to include the latest research evidence and establish a new consensus that has broader coverage, is more practical and is more in line with China's national conditions. This new expert consensus includes new concept of HS, recommendations for laboratory tests and auxiliary examinations, new understanding of diagnosis and differential diagnosis, On-site emergency treatment and In-hospital treatment, translocation of HS patients and prevention of HS.

Expert consensus on the diagnosis and treatment of thrombocytopenia in adult critical care patients in China

“…Heatstrokeinduced DIC also requires anticoagulation therapy while replenishing coagulation substrates. Unfractionated heparin is the preferred treatment [112].…”

Design and in silico study of the novel coumarin derivatives against SARS-CoV-2 main enzymes

“…When the coronavirus first appeared in Wuhan, Hubei province, China in December 2019, its source was unknown and traces of pneumonia were visible in patients carrying the virus (Huang et al, 2020 ; Lu et al, 2020 ; Zu et al, 2020 ). This virus, which was found to belong to the coronavirus family, was first named 2019-nCoV (2019-novel CoronaVirus), and then the World Health Organization changed this name to SARS-CoV-2 (Severe Acute Respiratory Syndrome-Corona Virus-2) due to its close similarity to SARS-CoV (Gorbalenya et al, 2020 ; Guo et al, 2020 ). The disease caused by the coronavirus (COVID-19) is highly contagious and spreads rapidly from person to person.…”

Evaluation of certain medicinal plants compounds as new potential inhibitors of novel corona virus (COVID-19) using molecular docking analysis

“…The world faces a severe and acute public health emergency due to the ongoing global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Wu and McGoogan 2020 ). SARS-CoV-2 is a new strain of coronavirus that appeared in China in December 2019 (Guo et al 2020 ). Symptoms of COVID-19 can be relatively non-specific and infected people may be asymptomatic.…”